CORESTEM is a biotechnology company specializing in the research and development of personalized stem cell therapies for ... NeuroNata-R is based on autologous bone marrow-derived mesenchymal ...

The partnership aims to industrialize the world’s first clinical-stage autologous induced pluripotent stem cell (iPSC)-derived cell therapy for peripheral artery disease (PAD) and coronary ...

Cell therapy is a field rife with innovation, but most of the novel therapies being developed fall into one of two basic categories: autologous cell therapies, which involve removing a patient’s ...

While the field of regenerative medicine has been plagued with ethical issues owing to the use of fetal and embryonic materials and to the expansion of unregulated stem cell clinics that offer ...

Weeks after an injection of stem cells delivered to the brain, 80% of patients had improved CSF biomarkers with no adverse effects.

The Boao Lecheng International Medical Tourism Pilot Zone in Hainan province has released pricing for China's first batch of stem cell ... per session, autologous lung cell transplantation ...

CAMBRIDGE, Mass. & ATLANTA & SEOUL, South Korea, April 15, 2025--Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease ...